| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/14/2002 | WO2002012855A2 Method and system for rapid biomolecular recognition of amino acids and protein sequencing |
| 02/14/2002 | WO2002012854A2 Systems and methods for providing information concerning chromophores in physiological media |
| 02/14/2002 | WO2002012568A2 Cell-based analysis of high throughput screening data for drug discovery |
| 02/14/2002 | WO2002012566A2 The use and evaluation of a [2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
| 02/14/2002 | WO2002012565A1 Association of sim2 with cancer |
| 02/14/2002 | WO2002012559A1 Kits for extracting nucleic acid and method of extracting nucleic acid by using the kits |
| 02/14/2002 | WO2002012558A1 Method of an apparatus for the detection of analytes |
| 02/14/2002 | WO2002012549A1 Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites |
| 02/14/2002 | WO2002012548A1 METHOD OF ANALYZING NFλB ACTIVITY |
| 02/14/2002 | WO2002012547A1 Multiplexed enzymatic assays |
| 02/14/2002 | WO2002012546A2 Biosensor arrays and methods |
| 02/14/2002 | WO2002012545A2 Method of identifying immunosuppressive agents |
| 02/14/2002 | WO2002012544A2 Identification of short chain dehydrogenases/reductases (sdr) |
| 02/14/2002 | WO2002012515A1 Assays for alternative lengthening of telomeres |
| 02/14/2002 | WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012470A2 A member of the lysyl oxidase gene family |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012448A1 Methods for culturing human lung mast cells and uses thereof |
| 02/14/2002 | WO2002012447A2 Isolation and use of solid tumor stem cells |
| 02/14/2002 | WO2002012445A1 Detection of cox-2 activity and anandamide metabolites |
| 02/14/2002 | WO2002012443A2 Active nems arrays for biochemical analyses |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
| 02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | WO2002012325A2 Suppressor gene |
| 02/14/2002 | WO2002012290A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/14/2002 | WO2002012279A2 Schizophrenia related gene and protein |
| 02/14/2002 | WO2002012274A2 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | WO2002012270A1 Peptides capable of functioning as mimotopes for estradiol analytes |
| 02/14/2002 | WO2002012263A1 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
| 02/14/2002 | WO2002012262A1 IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA |
| 02/14/2002 | WO2002012251A1 Detection of analytes in aqueous environments |
| 02/14/2002 | WO2002012195A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 02/14/2002 | WO2002012129A1 Low-level boron detection and measurement |
| 02/14/2002 | WO2002011889A1 Highly parallel fabrication of microarrays by ink jet printheads |
| 02/14/2002 | WO2002011767A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 02/14/2002 | WO2002011708A2 Methods for inducing apolipoprotein e secretion |
| 02/14/2002 | WO2002011606A2 Diagnostic tests for anti-endotoxin core antibodies |
| 02/14/2002 | WO2001098471A8 Human phosphodiesterases |
| 02/14/2002 | WO2001081896B1 An ultra-fast nucleic acid sequencing device and a method for making and using the same |
| 02/14/2002 | WO2001073018A3 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 02/14/2002 | WO2001072838A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/14/2002 | WO2001072328A3 Methods of treating diseases with activated protein c |
| 02/14/2002 | WO2001069233A3 Sampling device for gas analyses of raw coke oven gases and other contaminated gases and method for analysis thereof |
| 02/14/2002 | WO2001067106A8 Identification of g protein-coupled receptor ligands and modulators |
| 02/14/2002 | WO2001064874A3 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/14/2002 | WO2001063217A3 Calibration of array-based sensing system |
| 02/14/2002 | WO2001062954A8 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 02/14/2002 | WO2001059163A3 Method for detecting and quantifying adenovirus |
| 02/14/2002 | WO2001059120A3 Il-17 like molecules and uses thereof |
| 02/14/2002 | WO2001059096A9 Method of detecting ligand or ligand-like low-molecular weight compound |
| 02/14/2002 | WO2001058951A3 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 02/14/2002 | WO2001058921A3 Methods and compositions for generating angiostatin |
| 02/14/2002 | WO2001058915A3 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 02/14/2002 | WO2001057522A3 Immunochromatographic methods which employ semiconductor nanocrystals |
| 02/14/2002 | WO2001057248A3 Polynucleotide arrays and their use in sequencing |
| 02/14/2002 | WO2001055346A3 System for the internal qualitative and quantitative validation of marker indices |
| 02/14/2002 | WO2001054814A3 Compositions and methods for performing biological reactions |
| 02/14/2002 | WO2001050129A3 Compensation for non-specific signals in quantitative immunoassays |
| 02/14/2002 | WO2001046692A3 Measuring method by means of addition of at least one biological receptor cell and a suitable device for carrying out said method |
| 02/14/2002 | WO2001046682A3 Method and device for the in situ detection of the degree of conversion of a non-magnetic phase in a ferromagnetic phase of a metallic work piece |
| 02/14/2002 | WO2001046457A3 Amperometric biosensor test strip |
| 02/14/2002 | WO2001043634A3 Method of improving reproducibility of non-invasive measurements |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | WO2001040771A3 Apparatus and method for analyzing fluids |
| 02/14/2002 | WO2001037852A3 Methods of inhibiting atrophy or promoting hypertrophy |
| 02/14/2002 | WO2001036973A3 Method for solubilising optical markers |
| 02/14/2002 | WO2001036589A3 Human ex vivo immune system |
| 02/14/2002 | WO2001032828A3 Biological fluid processing |
| 02/14/2002 | WO2001025489A3 Diagnostic and therapeutic uses for a gene differentially expressed in prostate cancer |
| 02/14/2002 | WO2001021771A3 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 02/14/2002 | WO2001020329A3 Test systems and sensors for detecting molecular binding events |
| 02/14/2002 | WO2001014885A3 Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay |
| 02/14/2002 | WO2000065062A3 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 02/14/2002 | WO2000023617A3 Housing box for electronic chip with biological probes |
| 02/14/2002 | WO2000009552A9 Secreted proteins and polynucleotides encoding them |
| 02/14/2002 | US20020019994 Classification of plants; obtain plant, isolate amylase, monitor amylase for heat resistance, classify plant |
| 02/14/2002 | US20020019991 Compositions containing an alpha 1,2-fucose linkage and uses thereof |
| 02/14/2002 | US20020019746 Aggregating persons with a select profile for further medical characterization |
| 02/14/2002 | US20020019707 Glucose metering system |
| 02/14/2002 | US20020019706 Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade |
| 02/14/2002 | US20020019705 System and method for analysis of genetic networks |
| 02/14/2002 | US20020019615 Disposable article having a proactive sensor |
| 02/14/2002 | US20020019553 Chemiluminescence |
| 02/14/2002 | US20020019519 KIAA0551 polynucleotides and polypeptides use |
| 02/14/2002 | US20020019518 A sublancin peptide variant (lantibody) having a spacer region and a subtilin leader peptide to provide an anchoring means for inserting and retaining the lantibody in a host cell wall; genetic engineering; bactericides; viricides; kits |
| 02/14/2002 | US20020019517 Fibronectins for use as diagnostic and treatment tools in gene therapy |
| 02/14/2002 | US20020019515 Novel spoIIIE |
| 02/14/2002 | US20020019514 Nucleotide sequences coding fusion protein for use in the detection and treatment of diabetes, autoimmune disease and arthritis |
| 02/14/2002 | US20020019481 Non-luminescent substrate |
| 02/14/2002 | US20020019407 Methylxanthines in the diagnosis and treatment of autistic disorder |
| 02/14/2002 | US20020019330 Screening drug candidates comprising providing a cell that expresses an expression profile gene encoding a protein (AAA9) or fragment, adding a drug candidate to the cell, determining the effect of the drug candidate |
| 02/14/2002 | US20020019062 Assay devices |
| 02/14/2002 | US20020019060 Device for analyzing a fluid sample |
| 02/14/2002 | US20020019057 Ferrocenyl boronate derivatization of chemical compounds undergoing mass spectrometry analysis |
| 02/14/2002 | US20020019056 Qualitative and quantitative analysis in biological samples by esterifying acid and using tandem mass spectroscopy using atmospheric pressure ionization techniques in the positive mode; diagnosis of vitamin B12 deficiency |
| 02/14/2002 | US20020019055 Extraction through the skin or hair using a 2-pyrrolidone in a carrier; drugs of abuse, caffeine, prescription drugs, e.g. acetaminophen, metabolic analytes, e.g., blood glucose and heavy metals, e.g. lead, lithium, copper and iron |
| 02/14/2002 | US20020019053 Hematology control and system for multi-parameter hematology measurements |